Diagnosis of isolated cardiac sarcoidosis based on new guidelines

Abstract Aims In the updated guidelines for cardiac sarcoidosis (CS) proposed by the Japanese Circulation Society (JCS), the definition of isolated CS (iCS) was established for the first time. This prompted us to examine the characteristics of patients with CS including iCS according to them by revi...

Full description

Bibliographic Details
Main Authors: Hideki Kawai, Masayoshi Sarai, Yasuchika Kato, Hiroyuki Naruse, Ayumi Watanabe, Takahiro Matsuyama, Hiroshi Takahashi, Sadako Motoyama, Junnichi Ishii, Shin‐ichiro Morimoto, Hiroshi Toyama, Yukio Ozaki
Format: Article
Language:English
Published: Wiley 2020-10-01
Series:ESC Heart Failure
Subjects:
Online Access:https://doi.org/10.1002/ehf2.12853
_version_ 1818915446853730304
author Hideki Kawai
Masayoshi Sarai
Yasuchika Kato
Hiroyuki Naruse
Ayumi Watanabe
Takahiro Matsuyama
Hiroshi Takahashi
Sadako Motoyama
Junnichi Ishii
Shin‐ichiro Morimoto
Hiroshi Toyama
Yukio Ozaki
author_facet Hideki Kawai
Masayoshi Sarai
Yasuchika Kato
Hiroyuki Naruse
Ayumi Watanabe
Takahiro Matsuyama
Hiroshi Takahashi
Sadako Motoyama
Junnichi Ishii
Shin‐ichiro Morimoto
Hiroshi Toyama
Yukio Ozaki
author_sort Hideki Kawai
collection DOAJ
description Abstract Aims In the updated guidelines for cardiac sarcoidosis (CS) proposed by the Japanese Circulation Society (JCS), the definition of isolated CS (iCS) was established for the first time. This prompted us to examine the characteristics of patients with CS including iCS according to them by reviewing patients undergoing 18F‐fluoro‐2‐deoxyglucose positron‐emission tomography/computerized tomography (FDG‐PET/CT), compared with those with CS determined by the conventional international criteria. Methods and results From 2013 to 2019, 94 patients (61 ± 15 years, 50 female patients) with suspected CS underwent whole‐body and cardiac FDG‐PET/CT scanning. In contrast to 22 patients with CS based on the international criteria, 34 [27 with systemic sarcoidosis including cardiac involvement (sCS) and 7 with clinical iCS] were diagnosed with CS according to the new JCS guidelines (P = 0.012), and 60 were not (4 suspected iCS, 13 systematic sarcoidosis without cardiac involvement, and 43 no sarcoidosis). In addition to 26 of 34 patients with CS, corticosteroids were also started in 6 of 60 without CS according to clinical need. Conclusions Diagnostic yield with the new JCS guidelines was higher, with approximately 1.5‐fold of the patients diagnosed with CS compared with the previous international criteria and clinical iCS accounting for approximately 20% of the whole CS cohort. In addition to 75% of the patients with sCS or clinical iCS in the updated guidelines, 10% in whom CS was not documented were also started on corticosteroids for clinical indications such as reduced cardiac function or arrhythmia.
first_indexed 2024-12-20T00:02:25Z
format Article
id doaj.art-a797fe574e254e8fb93b2a9cf8094e3a
institution Directory Open Access Journal
issn 2055-5822
language English
last_indexed 2024-12-20T00:02:25Z
publishDate 2020-10-01
publisher Wiley
record_format Article
series ESC Heart Failure
spelling doaj.art-a797fe574e254e8fb93b2a9cf8094e3a2022-12-21T20:00:47ZengWileyESC Heart Failure2055-58222020-10-01752662267110.1002/ehf2.12853Diagnosis of isolated cardiac sarcoidosis based on new guidelinesHideki Kawai0Masayoshi Sarai1Yasuchika Kato2Hiroyuki Naruse3Ayumi Watanabe4Takahiro Matsuyama5Hiroshi Takahashi6Sadako Motoyama7Junnichi Ishii8Shin‐ichiro Morimoto9Hiroshi Toyama10Yukio Ozaki11Department of Cardiology Fujita Health University 1‐98 Dengakugakubo Toyoake JapanDepartment of Cardiology Fujita Health University 1‐98 Dengakugakubo Toyoake JapanDepartment of Cardiology Fujita Health University 1‐98 Dengakugakubo Toyoake JapanDepartment of Cardiology Fujita Health University 1‐98 Dengakugakubo Toyoake JapanDepartment of Radiology Fujita Health University Toyoake JapanDepartment of Radiology Fujita Health University Toyoake JapanDivision of Statistics Fujita Health University Toyoake JapanDepartment of Cardiology Fujita Health University 1‐98 Dengakugakubo Toyoake JapanDepartment of Cardiology Fujita Health University 1‐98 Dengakugakubo Toyoake JapanDepartment of Cardiology Fujita Health University 1‐98 Dengakugakubo Toyoake JapanDepartment of Radiology Fujita Health University Toyoake JapanDepartment of Cardiology Fujita Health University 1‐98 Dengakugakubo Toyoake JapanAbstract Aims In the updated guidelines for cardiac sarcoidosis (CS) proposed by the Japanese Circulation Society (JCS), the definition of isolated CS (iCS) was established for the first time. This prompted us to examine the characteristics of patients with CS including iCS according to them by reviewing patients undergoing 18F‐fluoro‐2‐deoxyglucose positron‐emission tomography/computerized tomography (FDG‐PET/CT), compared with those with CS determined by the conventional international criteria. Methods and results From 2013 to 2019, 94 patients (61 ± 15 years, 50 female patients) with suspected CS underwent whole‐body and cardiac FDG‐PET/CT scanning. In contrast to 22 patients with CS based on the international criteria, 34 [27 with systemic sarcoidosis including cardiac involvement (sCS) and 7 with clinical iCS] were diagnosed with CS according to the new JCS guidelines (P = 0.012), and 60 were not (4 suspected iCS, 13 systematic sarcoidosis without cardiac involvement, and 43 no sarcoidosis). In addition to 26 of 34 patients with CS, corticosteroids were also started in 6 of 60 without CS according to clinical need. Conclusions Diagnostic yield with the new JCS guidelines was higher, with approximately 1.5‐fold of the patients diagnosed with CS compared with the previous international criteria and clinical iCS accounting for approximately 20% of the whole CS cohort. In addition to 75% of the patients with sCS or clinical iCS in the updated guidelines, 10% in whom CS was not documented were also started on corticosteroids for clinical indications such as reduced cardiac function or arrhythmia.https://doi.org/10.1002/ehf2.12853Cardiac sarcoidosisFluorine‐18‐fluorodeoxyglucose positron emission tomographyIsolated cardiac sarcoidosis
spellingShingle Hideki Kawai
Masayoshi Sarai
Yasuchika Kato
Hiroyuki Naruse
Ayumi Watanabe
Takahiro Matsuyama
Hiroshi Takahashi
Sadako Motoyama
Junnichi Ishii
Shin‐ichiro Morimoto
Hiroshi Toyama
Yukio Ozaki
Diagnosis of isolated cardiac sarcoidosis based on new guidelines
ESC Heart Failure
Cardiac sarcoidosis
Fluorine‐18‐fluorodeoxyglucose positron emission tomography
Isolated cardiac sarcoidosis
title Diagnosis of isolated cardiac sarcoidosis based on new guidelines
title_full Diagnosis of isolated cardiac sarcoidosis based on new guidelines
title_fullStr Diagnosis of isolated cardiac sarcoidosis based on new guidelines
title_full_unstemmed Diagnosis of isolated cardiac sarcoidosis based on new guidelines
title_short Diagnosis of isolated cardiac sarcoidosis based on new guidelines
title_sort diagnosis of isolated cardiac sarcoidosis based on new guidelines
topic Cardiac sarcoidosis
Fluorine‐18‐fluorodeoxyglucose positron emission tomography
Isolated cardiac sarcoidosis
url https://doi.org/10.1002/ehf2.12853
work_keys_str_mv AT hidekikawai diagnosisofisolatedcardiacsarcoidosisbasedonnewguidelines
AT masayoshisarai diagnosisofisolatedcardiacsarcoidosisbasedonnewguidelines
AT yasuchikakato diagnosisofisolatedcardiacsarcoidosisbasedonnewguidelines
AT hiroyukinaruse diagnosisofisolatedcardiacsarcoidosisbasedonnewguidelines
AT ayumiwatanabe diagnosisofisolatedcardiacsarcoidosisbasedonnewguidelines
AT takahiromatsuyama diagnosisofisolatedcardiacsarcoidosisbasedonnewguidelines
AT hiroshitakahashi diagnosisofisolatedcardiacsarcoidosisbasedonnewguidelines
AT sadakomotoyama diagnosisofisolatedcardiacsarcoidosisbasedonnewguidelines
AT junnichiishii diagnosisofisolatedcardiacsarcoidosisbasedonnewguidelines
AT shinichiromorimoto diagnosisofisolatedcardiacsarcoidosisbasedonnewguidelines
AT hiroshitoyama diagnosisofisolatedcardiacsarcoidosisbasedonnewguidelines
AT yukioozaki diagnosisofisolatedcardiacsarcoidosisbasedonnewguidelines